Semaglutide is an antidiabetic indicated for the treatment of type 2 diabetes, as it acts by stimulating the production of insulin by the pancreas and decreasing the production of glucagon, which helps to reduce the levels of glucose in the bloodstream, when associated with a healthy diet and practice of regular physical exercise.
In addition, semaglutide, with the trade name Wegovy, is for weight loss, in people who suffer from obesity or overweight, as it promotes satiety, reducing hunger throughout the day, and, therefore, weight loss happens by reducing the number of calories consumed throughout the day.
Semaglutide can be found in pharmacies or drugstores, in the form of injection, with the name Ozempic, or in the form of tablets, such as Rybelsus, for the treatment of diabetes, sold upon presentation of a medical prescription, and should always be used with guidance from the endocrinologist.
What is it for
Semaglutide is indicated for the treatment of:
Uncontrolled type 2 diabetes mellitus, when only diet, physical exercises and/or use of other antidiabetics were not enough to control blood sugar levels;
Obesity with a BMI greater than 30 kg/m2.
Overweight with a BMI greater than 27 kg/m2, associated with diseases such as high blood pressure, diabetes mellitus, dyslipidemia or high cholesterol.
This medicine is a synthetic hormone, similar to glucagon produced naturally by the body, and which stimulates the production of insulin by the body, facilitating the control of blood sugar levels, when associated with a balanced diet and the practice of physical exercises.
Semaglutide for the treatment of diabetes can be used alone or in combination with other antidiabetic drugs, such as metformin, for example, only with medical guidance.
Semaglutide for weight loss
Semaglutide acts by stimulating the production of insulin by the pancreas, which reduces blood sugar levels, in addition to acting on areas of the brain involved in appetite regulation and promoting satiety, causing a reduction in the amount of calories ingested. daily and, therefore, this medicine also helps in weight loss, in cases of obesity or overweight.
In addition, in overweight or obese people who have diabetes, blood sugar levels are better regulated, making the sugar more easily used by the cells, and it ends up being deposited less in the form of fat.
Semaglutide for the treatment of obesity or overweight should only be used if recommended by the doctor and should be part of a balanced diet guided by a nutritionist and regular physical activity.
who cannot use
Semaglutide should not be used by people who are allergic to any of the components of the formula or by people with type 1 diabetes or diabetic ketoacidosis.
This medicine should also not be used by children and adolescents under 18 years of age, and by women who are pregnant or breastfeeding.
In addition, people with kidney or pancreas problems, stomach problems such as hiatal hernia or gastroesophageal reflux, or people who are using other medications, should inform their doctor about these conditions before starting semaglutide.
Care during treatment
Some precautions during treatment with semaglutide are important, such as:
Do not use semaglutide unless instructed by your doctor.
Take or apply semaglutide at the right times as directed by your doctor.
Do not increase the dose of semaglutide on your own, but only after medical evaluation and indication.
Inform your doctor of all medications you use, including vitamins or dietary supplements, as semaglutide may interfere with the absorption of these medications
Do the diet and physical exercises recommended by the doctor.
Eat in small amounts and at shorter intervals.
Drink at least 2 L of water a day to keep your body hydrated and avoid dehydration in case of diarrhea or vomiting.
Avoid very hot foods, as the steam from the food can cause nausea and vomiting.
Avoid consuming alcoholic beverages.
Tell your doctor immediately if you become pregnant during treatment.
In addition, medical follow-up should be carried out regularly and the side effects of semaglutide should be communicated to the physician, so that the treatment can be reassessed.
RL WEB 